From SARS to the Omicron variant of COVID-19: China's policy adjustments and changes to prevent and control infectious diseases

被引:17
|
作者
Luo, Mingyu [1 ]
Liu, Qinmei [1 ]
Wang, Jinna [1 ]
Gong, Zhenyu [1 ]
机构
[1] Zhejiang Prov Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China
关键词
COVID-19; infectious disease; physical containment strategies; vaccination; global health; public health;
D O I
10.5582/bst.2021.01535
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The COVID-19 pandemic has been the biggest public health crisis in a century. Since it was initially reported in 2019, the duration and intensity of its impacts are still in serious question around the world, and it is about to enter its third year. The first public health revolution failed to achieve its ultimate targets, as previously contained infectious diseases seem to have returned, and new infectious diseases continue to emerge. The prevention and control of infectious diseases is still a public health priority worldwide. After SARS, China adjusted a series of its infectious disease policies. In order to ensure the effectiveness and implementation of prevention and control interventions, the government should integrate the concept of public health. Perhaps we need a global public health system at the government level to fight the potential threat of infectious disease. This system could include multifaceted strategies, not just specific prevention and control interventions, and it could also be a comprehensive system to ensure unimpeded communication and cooperation as well as sustainable development.
引用
收藏
页码:418 / 423
页数:6
相关论文
共 50 条
  • [41] The impacts of coronavirus disease 2019 (COVID-19) preventive and control interventions on other infectious diseases in China
    Meng, X. J.
    Huang, X.
    Zhou, F.
    Wang, Y. W.
    Li, C. H.
    Wu, A. H.
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2022, 43 (08) : 1096 - 1098
  • [42] REDUCED DISEASE SEVERITY DURING THE OMICRON VARIANT COVID-19 OUTBREAK IN FUYANG CITY, CHINA
    Li, Shasha
    Jiang, Ning
    Jeyarajan, Andre
    Tan, Lin
    Li, Ming
    Duan, Xiaoqiong
    Han, Mingfeng
    Li, Xiuyong
    Lin, Wenyu
    HEPATOLOGY, 2022, 76 : S552 - S553
  • [43] Comparison of Omicron and Delta Variant Infection COVID-19 Cases - Guangdong Province, China, 2022
    Hu, Ting
    Zhang, Meng
    Deng, Aiping
    Zhang, Yingtao
    Li, Bosheng
    Li, Yan
    Kang, Min
    CHINA CDC WEEKLY, 2022, 4 (18): : 385 - 388
  • [44] FDA's Policy Changes for COVID-19 At-Home Diagnostics-Implications for Addressing Other Infectious Diseases and Future Pandemics
    Gottlieb, Scott
    JAMA HEALTH FORUM, 2021, 2 (12):
  • [45] China's successful control COVID-19
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2020, 20 (11): : 1240 - 1241
  • [46] Dynamic changes of Bacterial Microbiomes in Oropharynx during Infection and Recovery of COVID-19 Omicron Variant
    Cui, Guangying
    Sun, Ying
    Zou, Yawen
    Sun, Ranran
    Gao, Yanxia
    Liu, Xiaorui
    Zhou, Yongjian
    Zhang, Donghua
    Wang, Xueqing
    Li, Yonghong
    Liu, Liwen
    Zhang, Guizhen
    Rao, Benchen
    Yu, Zujiang
    Ren, Zhigang
    PLOS PATHOGENS, 2024, 20 (04)
  • [47] A distributed digital twin implementation of a hemodialysis unit aimed at helping prevent the spread of the Omicron COVID-19 variant
    Possik, Jalal
    Azar, Danielle
    Solis, Adriano O.
    Asgary, Ali
    Zacharewicz, Gregory
    Karami, Abir
    Tofighi, Mohammadali
    Najafabadi, Mahdi
    Shafiee, Mohammad A.
    Merchant, Asad A.
    Aarabi, Mehdi
    Wu, Jianhong
    2022 IEEE/ACM 26TH INTERNATIONAL SYMPOSIUM ON DISTRIBUTED SIMULATION AND REAL TIME APPLICATIONS (DS-RT), 2022,
  • [48] COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
    Cai, Qingxian
    Huang, Deliang
    Ou, Pengcheng
    Yu, Hong
    Zhu, Zhibin
    Xia, Zhang
    Su, Yinan
    Ma, Zhenghua
    Zhang, Yiming
    Li, Zhiwei
    He, Qing
    Liu, Lei
    Fu, Yang
    Chen, Jun
    ALLERGY, 2020, 75 (07) : 1742 - 1752
  • [49] The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic Diseases
    Geng, Yan
    Fan, Yong
    Deng, Xuerong
    Wang, Yu
    Zhao, Juan
    Ji, Lanlan
    Song, Zhibo
    Li, Guangtao
    Zhang, Xiaohui
    Sun, Xiaoying
    Huang, Hong
    Xie, Wenhui
    Zhang, Zhuoli
    RHEUMATOLOGY AND THERAPY, 2023, 10 (04) : 1039 - 1053
  • [50] The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic Diseases
    Yan Geng
    Yong Fan
    Xuerong Deng
    Yu Wang
    Juan Zhao
    Lanlan Ji
    Zhibo Song
    Guangtao Li
    Xiaohui Zhang
    Xiaoying Sun
    Hong Huang
    Wenhui Xie
    Zhuoli Zhang
    Rheumatology and Therapy, 2023, 10 : 1039 - 1053